FDA clears DiA's cardiac ultrasound AI

By AuntMinnie.com staff writers

October 29, 2020 -- Echocardiography image analysis software developer DiA Imaging Analysis has received clearance from the U.S. Food and Drug Administration (FDA) for its LVivo Seamless cardiac ultrasound artificial intelligence (AI) software.

LVivo chooses the best cardiac ultrasound views from standard echocardiogram exams and works with the company's other LVivo offerings such as LVivo EF for automated calculation of ejection fraction, it said.

DiA plans to highlight LVivo at the upcoming virtual RSNA meeting.


Copyright © 2020 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: